Bristol-Myers Squibb Stock
StockStockPrice
Historical dividends and forecast
Bristol-Myers Squibb has so far distributed $2.40 in 2024. The next dividend will be paid on 01.02.2025
CHART BY
Frequently asked questions
What is Bristol-Myers Squibb's market capitalization?
What is the Earnings Per Share (EPS) for Bristol-Myers Squibb?
What are the analyst ratings and target price for Bristol-Myers Squibb's stock?
What is Bristol-Myers Squibb's revenue over the trailing twelve months?
What is the EBITDA for Bristol-Myers Squibb?
What is the free cash flow of Bristol-Myers Squibb?
What is the 5-year beta of Bristol-Myers Squibb's stock?
How many employees does Bristol-Myers Squibb have, and what sector and industry does it belong to?
What is the free float of Bristol-Myers Squibb's shares?
Financials
Market Cap
$119.70B5Y beta
0.45EPS (TTM)
-$3.597Free Float
2.03BRevenue (TTM)
$47.44BEBITDA (TTM)
$21.31BFree Cashflow (TTM)
$9.00BPricing
Analyst Ratings
The price target is $52.10 and the stock is covered by 25 analysts.
Buy
6
Hold
18
Sell
1
Information
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.
34,100
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker